138 related articles for article (PubMed ID: 36472509)
41. Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
Paladino JA; Gilliland-Johnson KK; Adelman MH; Cohn SM
Surg Infect (Larchmt); 2008 Jun; 9(3):325-33. PubMed ID: 18570574
[TBL] [Abstract][Full Text] [Related]
42. Temporary Abdominal Closure Is Associated with Increased Risk for Fungal Intra-Abdominal Infections in Trauma Patients.
Zhang CX; Rasane RR; Zhang Q; Fonseca RA; Aldana JA; Rincon JE; Sorini MJ; Bochicchio KM; Leonard JM; Ilahi ON; Bochicchio GV
Surg Infect (Larchmt); 2020 Nov; 21(9):745-751. PubMed ID: 32186973
[No Abstract] [Full Text] [Related]
43. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of antibiotic consumption and microorganism resistance changes].
Galinyte D; Maciulaitis R; Budnikas V; Kubilius D; Varanaviciene B; Vitkauskiene A; Jokimas J; Jodkonis L
Medicina (Kaunas); 2008; 44(10):751-67. PubMed ID: 19001833
[TBL] [Abstract][Full Text] [Related]
45. Inclusion of Vancomycin as Part of Broad-Spectrum Coverage Does Not Improve Outcomes in Patients with Intra-Abdominal Infections: A Post Hoc Analysis.
Sanders JM; Tessier JM; Sawyer RG; Lipsett PA; Miller PR; Namias N; O'Neill PJ; Dellinger EP; Coimbra R; Guidry CA; Cuschieri J; Banton KL; Cook CH; Moore BJ; Duane TM
Surg Infect (Larchmt); 2016 Dec; 17(6):694-699. PubMed ID: 27483362
[TBL] [Abstract][Full Text] [Related]
46. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections.
Chong YP; Bae IG; Lee SR; Chung JW; Jun JB; Choo EJ; Moon SY; Lee MS; Jeon MH; Song EH; Lee EJ; Park SY; Kim YS
PLoS One; 2015; 10(4):e0119956. PubMed ID: 25910171
[TBL] [Abstract][Full Text] [Related]
47. Use of tigecycline in critically ill patients with serious nosocomial intra-abdominal infections.
Maseda E; Denis SE; Riquelme A; Gilsanz F
Rev Esp Quimioter; 2013 Mar; 26(1):56-63. PubMed ID: 23546465
[TBL] [Abstract][Full Text] [Related]
48. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
49. Clinical and microbiological characteristics of Ruminococcus gnavus bacteremia and intra-abdominal infection.
Watanabe N; Watari T; Otsuka Y; Hosokawa N; Yamagata K; Fujioka M
Anaerobe; 2024 Feb; 85():102818. PubMed ID: 38211774
[TBL] [Abstract][Full Text] [Related]
50. The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections.
Mikamo H; Monden K; Miyasaka Y; Horiuchi T; Fujimoto G; Fukuhara T; Yoshinari T; Rhee EG; Shizuya T
J Infect Chemother; 2019 Feb; 25(2):111-116. PubMed ID: 30528561
[TBL] [Abstract][Full Text] [Related]
51. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
[TBL] [Abstract][Full Text] [Related]
52. Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection.
Carson JG; Turpin RS; Hu H; Ma L; Wilson SE
Surg Infect (Larchmt); 2008 Feb; 9(1):15-21. PubMed ID: 18363464
[TBL] [Abstract][Full Text] [Related]
53. [Value of procalcitonin and critical illness score in etiological diagnosis and prognosis of sepsis caused by intra-abdominal infections].
Yan S; Lian R; Sun L; Jin Z; Zhao C; Zhang G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):792-797. PubMed ID: 34412746
[TBL] [Abstract][Full Text] [Related]
54. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
55. Intra-abdominal infection after radical gastrectomy for gastric cancer: Incidence, pathogens, risk factors and outcomes.
Xiao H; Xiao Y; Quan H; Liu W; Pan S; Ouyang Y
Int J Surg; 2017 Dec; 48():195-200. PubMed ID: 28751223
[TBL] [Abstract][Full Text] [Related]
56. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery.
Ho VP; Barie PS; Stein SL; Trencheva K; Milsom JW; Lee SW; Sonoda T
Surg Infect (Larchmt); 2011 Aug; 12(4):255-60. PubMed ID: 21790479
[TBL] [Abstract][Full Text] [Related]
57. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
[TBL] [Abstract][Full Text] [Related]
58. Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma.
Ra JH; Rattan R; Patel NJ; Bhattacharya B; Butts CA; Gupta S; Asfaw SH; Como JJ; Sahr SM; Bugaev N
J Trauma Acute Care Surg; 2023 Oct; 95(4):603-612. PubMed ID: 37316989
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
60. Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study.
De Pastena M; Paiella S; Azzini AM; Zaffagnini A; Scarlini L; Montagnini G; Maruccio M; Filippini C; Romeo F; Mazzariol A; Cascio GL; Bazaj A; Secchettin E; Bassi C; Salvia R
Surg Infect (Larchmt); 2021 Jun; 22(5):536-542. PubMed ID: 33095107
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
